2017
Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry
GODSCHALK, T. C., R. A. BYRNE, T. ADRIAENSSENS, N. MALIK, L. J. FELDMAN et. al.Základní údaje
Originální název
Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry
Autoři
GODSCHALK, T. C. (528 Nizozemské království), R. A. BYRNE (276 Německo), T. ADRIAENSSENS (56 Belgie), N. MALIK (826 Velká Británie a Severní Irsko), L. J. FELDMAN (250 Francie), G. GUAGLIUMI (380 Itálie), F. ALFONSO (724 Španělsko), F. J. NEUMANN (276 Německo), D. TRENK (276 Německo), M. JONER (276 Německo), C. SCHULZ (276 Německo), P. G. STEG (250 Francie), A. H. GOODALL (826 Velká Británie a Severní Irsko), R. WOJDYLA (616 Polsko), D. DUDEK (616 Polsko), J. J. WYKRZYKOWSKA (528 Nizozemské království), Ota HLINOMAZ (203 Česká republika, domácí), A. G. ZAMAN (826 Velká Británie a Severní Irsko), N. CURZEN (826 Velká Británie a Severní Irsko), J. DENS (56 Belgie), P. SINNAEVE (56 Belgie), W. DESMET (56 Belgie), A. H. GERSHLICK (826 Velká Británie a Severní Irsko), A. KASTRATI (276 Německo), S. MASSBERG (276 Německo) a J. M. TEN BERG (528 Nizozemské království, garant)
Vydání
JACC - Cardiovascular Interventions, New York, Elsevier Science Inc. 2017, 1936-8798
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 9.881
Kód RIV
RIV/00216224:14110/17:00113800
Organizační jednotka
Lékařská fakulta
UT WoS
000418483200014
Klíčová slova anglicky
aspirin; platelet aggregation; platelet function tests; P2Y(12) receptor antagonists; stent thrombosis
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 27. 4. 2020 13:18, Mgr. Tereza Miškechová
Anotace
V originále
OBJECTIVES High platelet reactivity (HPR) was studied in patients presenting with ST-segment elevation myocardial infarction (STEMI) due to stent thrombosis (ST) undergoing immediate percutaneous coronary intervention (PCI). BACKGROUND HPR on P2Y12 inhibitors (HPR-ADP) is frequently observed in stable patients who have experienced ST. The HPR rates in patients presenting with ST for immediate PCI are unknown. METHODS Consecutive patients presenting with definite ST were included in a multicenter ST registry. Platelet reactivity was measured before immediate PCI with the VerifyNow P2Y12 or Aspirin assay. RESULTS Platelet reactivity was measured in 129 ST patients presenting with STEMI undergoing immediate PCI. HPR-ADP was observed in 76% of the patients, and HPR on aspirin (HPR-AA) was observed in 13% of the patients. HPR rates were similar in patients who were on maintenance P2Y12 inhibitor or aspirin since stent placement versus those without these medications. In addition, HPR-ADP was similar in patients loaded with a P2Y12 inhibitor shortly before immediate PCI versus those who were not. In contrast, HPR-AA trended to be lower in patients loaded with aspirin as compared with those not loaded. CONCLUSIONS Approximately 3 out of 4 ST patients with STEMI undergoing immediate PCI had HPR-ADP, and 13% had HPR-AA. Whether patients were on maintenance antiplatelet therapy while developing ST or loaded with P2Y12 inhibitors shortly before undergoing immediate PCI had no influence on the HPR rates. This raises concerns that the majority of patients with ST have suboptimal platelet inhibition undergoing immediate PCI. (C) 2017 by the American College of Cardiology Foundation.